IHS Intrinsic Value

Intrinsic Value of IHS Overview

Key Highlights:
As of Mar 11, 2025 IHS Relative Value is $2.1, which is overvalued by 43.9%, compared to current share price of $3.7.
As of Mar 11, 2025 IHS DCF Value is N/A, which is undervalued by N/A, compared to current share price of $3.7.
Methodology
Price per share, $
Current share price
3.7
DCF value
not available

IHS Historical Intrinsic Value

Crunching data... Almost there!
Crunching data... Almost there!

IHS Valuation Metrics

LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
2.8x (as of Mar 11, 2025)
EV/Gross Profit
5.7x (as of Mar 11, 2025)
EV/EBIT
9.8x (as of Mar 11, 2025)
EV/EBITDA
(4.1x) (as of Mar 11, 2025)
EV/FCF
254.3x (as of Mar 11, 2025)
EV/OCF
15.8x (as of Mar 11, 2025)
P/Revenue
0.7x (as of Mar 11, 2025)
P/Gross Profit
1.4x (as of Mar 11, 2025)
P/EBIT
2.3x (as of Mar 11, 2025)
P/EBITDA
(1.0x) (as of Mar 11, 2025)
P/FCF
60.8x (as of Mar 11, 2025)
P/OCF
3.8x (as of Mar 11, 2025)
P/E
(0.5x) (as of Mar 11, 2025)
P/BV
(4.4x) (as of Mar 11, 2025)
PEG 1Y
0.1x (as of Mar 11, 2025)

IHS DCF Model

Free Cash Flow to Firm Model
NOPAT Model
Free Cash Flow to Equity Model
Net Income Model
Millions
Billions
Dec'19 ActualDec'20 ActualDec'21 ActualDec'22 ActualDec'23 ActualDec'24 EstimateDec'25 EstimateDec'26 EstimateDec'27 EstimateDec'28 EstimateDec'29 EstimateDec'30 EstimateDec'31 EstimateDec'32 EstimateDec'33 EstimateDec'34 Terminal
% growth
1,231.1
5.4%
1,403.1
14.0%
1,579.7
12.6%
1,961.3
24.2%
2,125.5
8.4%
1,695.6
(20.2%)
1,706.9
0.7%
1,834.4
7.5%
2,011.5
9.7%
2,003.7
(0.4%)
2,005.6
0.1%
2,017.1
0.6%
2,038.4
1.1%
2,069.8
1.5%
2,111.6
2.0%
2,164.4
2.5%
(98.1)
(8.0%)
331.9
23.7%
31.0
2.0%
(141.1)
(7.2%)
530.7
25.0%
(265.0)
(15.6%)
(266.8)
(15.6%)
(286.7)
(15.6%)
(314.4)
(15.6%)
(313.2)
(15.6%)
(313.5)
(15.6%)
(315.3)
(15.6%)
(318.6)
(15.6%)
(323.5)
(15.6%)
(330.1)
(15.6%)
(338.3)
(15.6%)
NOPAT
% effective tax rate
(101.4)
(8.2%)
700.8
49.9%
99.5
6.3%
(122.0)
(6.2%)
561.0
26.4%
(280.2)
(16.5%)
(282.1)
(16.5%)
(303.1)
(16.5%)
(332.4)
(16.5%)
(331.1)
(16.5%)
(331.4)
(16.5%)
(333.3)
(16.5%)
(336.8)
(16.5%)
(342.0)
(16.5%)
(348.9)
(16.5%)
(357.6)
(16.5%)
% of revenue
386.2
31.4%
411.3
29.3%
387.5
24.5%
476.0
24.3%
435.6
20.5%
391.7
23.1%
394.3
23.1%
423.7
23.1%
464.6
23.1%
462.8
23.1%
463.2
23.1%
465.9
23.1%
470.8
23.1%
478.1
23.1%
487.7
23.1%
499.9
23.1%
% of revenue
(258.3)
(21.0%)
(229.2)
(16.3%)
(402.5)
(25.5%)
(559.4)
(28.5%)
(598.8)
(28.2%)
(464.4)
(27.4%)
(467.5)
(27.4%)
(502.4)
(27.4%)
(550.9)
(27.4%)
(548.8)
(27.4%)
(549.3)
(27.4%)
(552.5)
(27.4%)
(558.3)
(27.4%)
(566.9)
(27.4%)
(578.3)
(27.4%)
(592.8)
(27.4%)
(18.1)
(1.5%)
(157.8)
(11.2%)
(69.8)
(4.4%)
(46.2)
(2.4%)
(225.0)
(10.6%)
(98.1)
(5.8%)
(98.8)
(5.8%)
(106.2)
(5.8%)
(116.4)
(5.8%)
(116.0)
(5.8%)
(116.1)
(5.8%)
(116.7)
(5.8%)
(118.0)
(5.8%)
(119.8)
(5.8%)
(122.2)
(5.8%)
(125.3)
(5.8%)
Free Cash Flow to Firm (FCFF)
% of revenue
8.4
0.7%
725.1
51.7%
14.7
0.9%
(251.6)
(12.8%)
172.8
8.1%
(451.1)
(26.6%)
(454.1)
(26.6%)
(488.0)
(26.6%)
(535.1)
(26.6%)
(533.1)
(26.6%)
(533.6)
(26.6%)
(536.6)
(26.6%)
(542.3)
(26.6%)
(550.6)
(26.6%)
(561.8)
(26.6%)
(575.8)
(26.6%)
% of FCFF used in calculation
Discount period
Discount factor
Discounted FCFF (DFCFF)

IHS DCF Value

Crunching data... Almost there!

IHS Earnings Power Value and Enterprise Value

Annual
LTM
Enterprise Value Breakdown
EPV and MIVoG as % of EV

IHS Reverse DCF

Implied FCF growth
Implied Revenue growth

Reverse DCF Assumptions and Outputs

as of Sep 30, 2024
Long-Term growth rate
2.5%
FX rate
1.0
Last share price
3.0
Implied FCF growth 1-10Y
0.0%

Implied Free Cash Flow growth vs Historical average vs Industry growth

Competing with IHS Intrinsic Value

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Enterprise Value
Intrinsic Value
DCF Value
Relative value
Ben Graham Revised fair value
Peter Lynch fair value
Earnings Power Value (EPV), % of EV
Market-Implied Value of Growth (MIVoG), % of EV
Reverse DCF (implied FCF growth)
Reverse DCF (implied Revenue growth)
$1,174.7M
$4,916.1M
$2.0
45.2% overvalued
N/A
$2.0
45.2% overvalued
Negative
368.2% overvalued
N/A
N/A
N/A
0.0%
0.0%
$301.6B
$410.1B
$57.8
77.5% overvalued
$25.1
90.0% overvalued
$90.6
64.7% overvalued
$140.5
45.2% overvalued
$153.1
40.4% overvalued
70.1%
29.9%
(1.0%)
(1.6%)
$187.9B
$325.6B
$25.1
3.6% overvalued
$28.3
9.0% undervalued
$21.8
16.0% overvalued
$53.1
104.3% undervalued
$37.1
42.5% undervalued
112.7%
(12.7%)
(19.6%)
(20.5%)
$182.3B
$346.4B
$111.2
156.1% undervalued
$176.5
306.0% undervalued
$45.9
5.7% undervalued
$70.1
61.3% undervalued
$60.0
38.2% undervalued
158.9%
(58.9%)
(19.5%)
(19.2%)
$137.5B
$229.3B
$90.8
152.7% undervalued
$132.0
267.0% undervalued
$49.6
38.1% undervalued
$40.2
11.8% undervalued
$47.5
32.1% undervalued
126.7%
(26.7%)
(11.7%)
(10.3%)
$51.6B
$145.1B
$516.8
45.2% undervalued
$678.7
91.0% undervalued
$354.8
0.3% overvalued
$366.8
3.1% undervalued
$348.2
2.1% overvalued
177.9%
(77.9%)
(13.5%)
(14.8%)
$44.9B
$82.2B
$65.9
354.2% undervalued
$41.4
186.0% undervalued
$90.3
522.6% undervalued
$35.9
147.7% undervalued
$241.8
1,567.5% undervalued
96.3%
3.7%
(4.0%)
(4.3%)
$30.2B
$30.2B
$44.4
14.7% undervalued
$36.5
6.0% overvalued
$52.4
35.1% undervalued
$76.9
98.3% undervalued
$208.0
436.7% undervalued
48.2%
51.8%
2.5%
3.1%
$27.4B
$22.9B
$26.7
159.5% undervalued
$13.5
31.0% undervalued
$39.9
287.8% undervalued
$38.4
273.3% undervalued
$40.5
293.9% undervalued
N/A
N/A
0.0%
0.0%
$25.8B
$64.9B
$17.1
271.0% undervalued
$24.3
428.0% undervalued
$9.8
113.8% undervalued
$40.6
781.6% undervalued
N/A
57.8%
42.2%
(22.5%)
(21.7%)
$23.4B
$44.0B
$14.4
6.2% overvalued
$21.3
38.0% undervalued
$7.6
50.8% overvalued
$5.7
63.0% overvalued
$6.7
56.6% overvalued
89.6%
10.4%
(5.2%)
(5.6%)

Intrinsic Valuation Tools

Wondering how to calculate intrinsic value of a stock? Use our intrinsic value tools to simplify complex valuation concepts and save time.